{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:14:07Z","timestamp":1778901247968,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN-167269"],"award-info":[{"award-number":["FRN-167269"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CRC-2020-00067"],"award-info":[{"award-number":["CRC-2020-00067"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","award":["1049314"],"award-info":[{"award-number":["1049314"]}],"id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.euo.2025.07.014","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:27:59Z","timestamp":1758788879000},"page":"352-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic Significance of the Cytoplasmic Expression of UDP-glucuronosyltransferase 2B17 in Localized Prostate Cancer: Insights from the Canadian Prostate Cancer Biomarker Network and PROCURE Multi-institutional Cohorts"],"prefix":"10.1016","volume":"9","author":[{"given":"Ashwini","family":"Uchil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Hovington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Brisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Simonyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Caron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Ouellet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Latour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armen","family":"Aprikian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ginette","family":"McKercher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Brimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladan","family":"Fazli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Fleshner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Gleave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Carmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zineb","family":"Hamilou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Trudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodorus","family":"van der Kwast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Mes-Masson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Guillemette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"L\u00e9vesque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.07.014_b0005","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/ng.3315","article-title":"Spatial genomic heterogeneity within localized, multifocal prostate cancer","volume":"47","author":"Boutros","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.euo.2025.07.014_b0010","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/s13059-014-0426-y","article-title":"Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer","volume":"15","author":"Wyatt","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.euo.2025.07.014_b0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eururo.2016.07.008","article-title":"Intratumoral and intertumoral genomic heterogeneity of multifocal localized prostate cancer impacts molecular classifications and genomic prognosticators","volume":"71","author":"Wei","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.07.014_b0020","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.281.17.1591","article-title":"Natural history of progression after PSA elevation following radical prostatectomy","volume":"281","author":"Pound","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2025.07.014_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215994","article-title":"UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways","volume":"553","author":"Lacombe","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.euo.2025.07.014_b0030","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.eururo.2013.03.058","article-title":"Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy","volume":"65","author":"Punnen","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.07.014_b0035","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S1470-2045(14)71021-6","article-title":"Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study","volume":"15","author":"Lalonde","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2025.07.014_b0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1470-2045(10)70295-3","article-title":"Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2025.07.014_b0045","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1073\/pnas.1215870110","article-title":"Development and validation of a 32-gene prognostic index for prostate cancer progression","volume":"110","author":"Wu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.euo.2025.07.014_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066855","article-title":"Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy","volume":"8","author":"Erho","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.euo.2025.07.014_b0055","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1073\/pnas.0304146101","article-title":"Gene expression profiling identifies clinically relevant subtypes of prostate cancer","volume":"101","author":"Lapointe","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.euo.2025.07.014_b0060","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1200\/JCO.2007.15.3155","article-title":"Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy","volume":"26","author":"Donovan","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2025.07.014_b0065","doi-asserted-by":"crossref","first-page":"7564","DOI":"10.1073\/pnas.0702507104","article-title":"Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity","volume":"104","author":"Saal","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.euo.2025.07.014_b0070","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.15252\/emmm.201505424","article-title":"Androgen receptor profiling predicts prostate cancer outcome","volume":"7","author":"Stelloo","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.euo.2025.07.014_b0075","doi-asserted-by":"crossref","first-page":"22855","DOI":"10.1074\/jbc.271.37.22855","article-title":"Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids","volume":"271","author":"Beaulieu","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.euo.2025.07.014_b0080","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41416-019-0722-0","article-title":"Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression","volume":"122","author":"Allain","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euo.2025.07.014_b0085","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41416-020-0749-2","article-title":"Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression","volume":"122","author":"Levesque","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euo.2025.07.014_b0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41416-022-02040-w","article-title":"Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer","volume":"128","author":"Rouleau","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euo.2025.07.014_b0095","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.1158\/0008-5472.CAN-16-1518","article-title":"UGT2B17 expedites progression of castration-resistant prostate cancers by promoting ligand-independent AR signaling","volume":"76","author":"Li","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.euo.2025.07.014_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002847","article-title":"Validation of the prognostic value of NF-kappaB p65 in prostate cancer: a retrospective study using a large multi-institutional cohort of the Canadian prostate cancer biomarker network","volume":"16","author":"Grosset","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.euo.2025.07.014_b0105","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.eururo.2015.06.054","article-title":"The UGT2B28 sex-steroid inactivation pathway is a regulator of steroidogenesis and modifies risk of prostate cancer progression","volume":"69","author":"Belledant","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.07.014_b0110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/bio.2013.0025","article-title":"Strategies for biochemical and pathologic quality assurance in a large multi-institutional biorepository; the experience of the PROCURE Quebec Prostate Cancer Biobank","volume":"11","author":"Brimo","year":"2013","journal-title":"Biopreserv Biobank"},{"key":"10.1016\/j.euo.2025.07.014_b0115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12894-018-0392-x","article-title":"The terry fox research institute Canadian prostate cancer biomarker network: an analysis of a pan-Canadian multi-center cohort for biomarker validation","volume":"18","author":"Ouellet","year":"2018","journal-title":"BMC Urol"},{"key":"10.1016\/j.euo.2025.07.014_b0120","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1124\/dmd.119.086330","article-title":"Factors affecting interindividual variability of hepatic UGT2B17 protein expression examined using a novel specific monoclonal antibody","volume":"47","author":"Emond","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.euo.2025.07.014_b0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.steroids.2015.07.009","article-title":"A chromatography\/tandem mass spectrometry method for the simultaneous profiling of ten endogenous steroids, including progesterone, adrenal precursors, androgens and estrogens, using low serum volume","volume":"104","author":"Caron","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.euo.2025.07.014_b0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/JU.0000000000004333","article-title":"High 11-ketotestosterone linked to shorter time to castration resistance in recurrent nonmetastatic prostate cancer","volume":"213","author":"Dahmani","year":"2025","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.07.014_b0135","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.3390\/cells11152329","article-title":"Uridine diphosphate glucuronosyl transferase 2B28 (UGT2B28) promotes tumor progression and is elevated in African American prostate cancer patients","volume":"11","author":"Ravindran","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.euo.2025.07.014_b0140","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/cells12091295","article-title":"A non-canonical role for the glycosyltransferase enzyme UGT2B17 as a novel constituent of the B cell receptor signalosome","volume":"12","author":"Wagner","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.euo.2025.07.014_b0145","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41416-020-0887-6","article-title":"UGT2B17 modifies drug response in chronic lymphocytic leukaemia","volume":"123","author":"Allain","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euo.2025.07.014_b0150","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature13283","article-title":"The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation","volume":"511","author":"Zahreddine","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.euo.2025.07.014_b0155","unstructured":"Feng T, Gao L, Jia Q, et al. Non-canonical functions of UGT2B17 promote castrate-resistant prostate cancer progression. In preparation."},{"key":"10.1016\/j.euo.2025.07.014_b0160","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2012-08-447359","article-title":"Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia","volume":"121","author":"Gruber","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.euo.2025.07.014_b0165","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.3324\/haematol.2015.136440","article-title":"UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?","volume":"101","author":"Bhoi","year":"2016","journal-title":"Haematologica"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125002068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125002068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:36:50Z","timestamp":1778899010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125002068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2588931125002068"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.07.014","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Significance of the Cytoplasmic Expression of UDP-glucuronosyltransferase 2B17 in Localized Prostate Cancer: Insights from the Canadian Prostate Cancer Biomarker Network and PROCURE Multi-institutional Cohorts","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}